Genomic determinants of resistance in newly diagnosed multiple myeloma treated with targeted-immunotherapy Meeting Abstract
| Authors: | Maura, F.; Boyle, E.; Coffey, D.; Maclachlan, K. H.; Diamond, B.; Blaney, P.; Gagler, D.; Ziccheddu, B.; Ghamlouch, H.; Wang, Y.; Hoffman, J. E.; Kazandjian, D.; Hassoun, H.; Guzman, E.; Mailankody, S.; Shah, U. A.; Tan, C.; Hultcrantz, M.; Scordo, M.; Shah, G. L.; Landau, H.; Chung, D. J.; Giralt, S. A.; Zhang, Y.; Dogan, A.; Lesokhin, A. M.; Verducci, D.; Davies, F. E.; Usmani, S.; Korde, N.; Morgan, G. J.; Landgren, O. |
| Abstract Title: | Genomic determinants of resistance in newly diagnosed multiple myeloma treated with targeted-immunotherapy |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1137 |
| End Page: | 1139 |
| Language: | English |
| ACCESSION: | WOS:000893223201056 |
| DOI: | 10.1182/blood-2022-160308 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
